AI assistant
CAMBIUM BIO LIMITED — Director's Dealing 2020
Nov 18, 2020
64666_rns_2020-11-18_ab216152-2095-406c-ad21-816c49099b02.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Regeneus Ltd ABN 13 127 035 358
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | John Chiplin |
|---|---|
| Date of last notice | 29thApril 2019 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | |
| Date of change | 13thNovember 2020 |
| No. of securities held prior to change | Nil |
| Class | N/A |
| Number acquired | 1,000,000 unlisted options exercisable at$0.1075 per share and expiring 31 August2025 |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Nil consideration – issue of options underemployee incentive scheme. Estimatedvalue of options is $118,180. |
| No. of securities held after change | 1,000,000 unlisted options exercisable at$0.1075 per share and expiring 31 August2025 |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Nature of change Issue of unlisted options under Regeneus’ Example: on-market trade, off-market trade, exercise of options, issue Option Share Trust Plan of securities under dividend reinvestment plan, participation in buyback
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011